Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Liberia receives ebola serum supply
Medical imagery
The serum treatment will be monitored by doctors in Liberia (stock photo)
Treatment is made from the blood of recovered survivors

Liberia has started to treat patients infected with Ebola with serum therapy - a treatment made from the blood of recovered survivors, the BBC reports.

It is hoped that the experimental treatment will help combat the virus that has been killing thousands of people throughout West Africa.

The ebola serum is made from the blood of survivors, which contain antibodies to fight off the virus. It is made by removing the red blood cells, whilst keeping the important antibodies - which can be used to treat other patients.

In the UK and US, Ebola patients have already received this form of treatment.

The serum treatment will be monitored by doctors in Liberia, who will monitor how safe and effective the therapy is.

A number of Liberian health care workers have been trained to give the serum.

Dr David Hoover, the programme's director, said: "This will empower local health care systems to become more self-sufficient and better serve their patients during this current epidemic as well as in the future."

Become a member or log in to add this story to your CPD history

Submissions open for BSAVA Clinical Research Abstracts 2026

News Story 1
 The BSAVA has opened submissions for the BSAVA Clinical Research Abstracts 2026.

It is an opportunity for applicants to present new research on any veterinary subject, such as the preliminary results of a study, discussion of a new technique or a description of an interesting case.

They must be based on high-quality clinical research conducted in industry, practice or academia, and summarised in 250 words.

Applications are welcome from vets, vet nurses, practice managers, and students.

Submissions are open until 6 March 2026. 

Click here for more...
News Shorts
Survey seeks ruminant sector views on antimicrobial stewardship

A new survey is seeking views of people working in the UK ruminant sector on how to tackle the challenge of demonstrating responsible antibiotic stewardship.

Forming part of a wider, collaborative initiative, the results will help identify the types of data available so that challenges with data collection can be better understood and addressed.

Anyone working in the UK farming sector, including vets and farmers,is encouraged to complete the survey, which is available at app.onlinesurveys.jisc.ac.uk